Impact of non‐obese metabolic dysfunction‐associated fatty liver disease on risk factors for the recurrence of esophageal squamous cell carcinoma treated with endoscopic submucosal dissection: A multicenter study

Aim Metabolic dysfunction is a risk factor for esophageal squamous cell carcinoma (ESCC). We investigated the impact of the recently proposed metabolic dysfunction‐associated fatty liver disease (MAFLD) and its subtypes on ESCC recurrence after endoscopic treatment. Methods This multicenter observat...

Ausführliche Beschreibung

Bibliographische Detailangaben

Veröffentlicht in:	Hepatology research 2024-02, Vol.54 (2), p.201-212
Hauptverfasser:	Fukunaga, Shuhei, Mukasa, Michita, Nakane, Tomoyuki, Nakano, Dan, Tsutsumi, Tsubasa, Chou, Tomonori, Tanaka, Hiroshi, Hayashi, Daiki, Minami, Shinpei, Ohuchi, Akihiro, Nagata, Tsutomu, Takaki, Kota, Takaki, Hiroshi, Miyajima, Ichiro, Nouno, Ryuichi, Araki, Toshihiro, Morita, Taku, Torimura, Takuji, Okabe, Yoshinobu, Kawaguchi, Takumi
Format:	Artikel
Sprache:	eng
Schlagworte:	Body mass index Endoscopy Esophageal cancer Esophageal carcinoma Fatty liver Liver diseases Metabolism non‐obese obesity overweight Risk factors Squamous cell carcinoma
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!